CROI 2017 Program and Information

Program and Agenda

775 PREGNANCIES INWOMENWHO ACQUIRED HIV PERINATALLY Mira Hleyhel 1 , Catherine Dollfus 2 , Roland Tubiana 3 , Christine Rouzioux 4 , Pierre Frange 4 , Stephane Blanche 4 , Jérôme Le Chenadec 1 , Albert Faye 5 , Laurent Mandelbrot 6 , Josiane Warszawski 1 1 INSERM, Le Kremlin-Bicetre, Paris, France, 2 Trousseau Hosp, Paris, France, 3 Pitié-Salpétrière Hosp, Paris, France, 4 Necker Hosp, Paris, France, 5 Univ Paris Diderot, Paris, France, 6 Univ Paris Diderot, Colombes, France 776 ANTENATAL ANTIRETROVIRAL THERAPY AND ADVERSE BIRTH OUTCOMES: THE PROMISE TRIAL Benjamin H. Chi 1 , Mona Farhad 2 , Maxensia Owor 3 , Tsungai Chipato 4 , Min Qin 2 , Sufia Dadabhia 5 , Devasena Gnanashanmugam 6 , Nahida Chakhtoura 7 , Mary Glenn Fowler 5 , Jeffrey S. Stringer 1 1 Univ of North Carolina at Chapel Hill, Chapel Hill, NC, USA, 2 Harvard Univ, Boston, MA, USA, 3 Makerere Univ–Johns Hopkins Univ Rsr Collab, Kampala, Uganda, 4 Univ of Zimbabwe, Harare, Zimbabwe, 5 The Johns Hopkins Univ, Baltimore, MD, USA, 6 DAIDS, NIAID, Rockville, MD, USA, 7 NICHD, Bethesda, MD, USA 777 RISK FACTORS FOR LOWBIRTHWEIGHT AND PRETERM DELIVERY IN THE PROMISE TRIAL Dorothy Sebikari 1 , Min Qin 2 , Maxensia Owor 1 , Jeffrey S. Stringer 3 , Mona Farhad 2 , Nahida Chakhtoura 4 , Benjamin H. Chi 3 , Karin Klingman 5 , Gerhard Theron 6 , Mary Glenn Fowler 7 1 Makerere Univ–Johns Hopkins Univ Rsr Collab, Kampala, Uganda, 2 Harvard Univ, Boston, MA, USA, 3 Univ of North Carolina at Chapel Hill, Chapel Hill, NC, USA, 4 NICHD, Bethesda, MD, USA, 5 DAIDS, NIAID, Bethesda, MD, USA, 6 Stellenbosch Univ, Cape Town, South Africa, 7 The Johns Hopkins Univ, Baltimore, MD, USA 778 DO HIV+WOMEN ON PROTEASE INHIBITORS DELIVER PRETERM? FINDINGS FROMA UK STUDY Graziella Favarato , Claire Townsend, Heather Bailey, Claire Thorne, for the UK and Ireland National Study of HIV in Pregnancy and Childhood (NSHPC) Univ Coll London, London, UK 779 TDF/FTC IN PREGNANCY SHOWS NO INCREASE IN ADVERSE INFANT BIRTH OUTCOMES IN US COHORTS Kathryn Rough 1 , George R. Seage 1 , Paige L. Williams 1 , Sonia Hernandez- Diaz 1 , Yanling Huo 1 , Ellen G. Chadwick 2 , Risa M. Hoffman 3 , Emily Barr 4 , David E. Shapiro 1 , Kunjal Patel 1 1 Harvard Univ, Boston, MA, USA, 2 Ann & Robert H. Lurie Children’s Hosp of Chicago, Chicago, IL, USA, 3 Univ of California Los Angeles, Los Angeles, CA, USA, 4 Children’s Hosp Colorado, Aurora, CO, USA Poster P-R3 PHARMACOKINETICS AND DOSING OF ARVs AND COTREATMENTS IN CHILDREN AND YOUTH Poster Hall - 4 EF 2:30 PM - 4:00 PM 806 DOLUTEGRAVIR PHARMACOKINETICS, SAFETY AND EFFICACY IN HIV+CHILDREN2 TO<6 YEARS OLD Theodore Ruel 1 , Edward Acosta 2 , Rajendra P. Singh 3 , Carmelita Alvero 4 , Kathleen George 5 , Stephanie Popson 6 , Cindy Vavro 7 , Rohan Hazra 8 , Andrew Wiznia 9 , for the P1093 Team 1 Univ of California, San Francisco, San Francisco, CA, USA, 2 Univ of Alabama at Birmingham, Birmingham, AL, USA, 3 GlaxoSmithKline, King of Prussia, PA, USA, 4 Harvard Univ, Boston, MA, USA, 5 FHI 360, Durham, NC, USA, 6 Frontier Sci & Tech Rsr Fndn, Inc., Amherst, NY, USA, 7 ViiV Hlthcare, Rsr Triangle Park, NC, USA, 8 NICHD, Bethesda, MD, USA, 9 Albert Einstein Coll of Med, Bronx, NY, USA

Poster Sessions • Thursday

CROI 2017 197